Abstract:Cancer is a serious threat to human life and health. It has become the leading cause of death worldwide. According to the National Cancer Center 2019 National Cancer Report, there were about 4 million new cases of cancer in China in 2015, and 8 people were diagnosed with cancer and 5 people died of cancer every minute. Currently, cancer remains a major threat to human health in China and is associated with a high mortality rate. While great efforts have been devoted to the development of cancer therapies, including surgery, radiotherapy, chemotherapy, traditional Chinese medicine, targeted therapy, and immunotherapy, most cancer therapies fail to achieve satisfactory efficacy, which is closely related to the lack of understanding of tumors in modern science, absence of major breakthroughs in the field of cancer research using key cutting-edge technologies, and limited translation and application of the achievements of basic research findings. Cancer represents a collection of multi-origin and multi-step systemic chronic diseases with various outcomes. The high heterogeneity of cancer poses a challenge for traditional therapeutic approaches to treat one type of tumor with the same method but provides opportunities to promote personalized therapies, including immunotherapy and targeted therapy. To promote original and innovative cancer research in China, it is essential to take advantage of modern genetic technology, stem cell technology, molecular imaging technology, molecular diagnosis, bioinformatics, innovative drug development, physical and chemical research methods, and alternative cutting-edge technologies, combined with extensive clinical data and patient population in China. For these reasons, the National Natural Science Foundation of China organized the 223rd Shuangqing Forum titled “Cancer Research Driven by Cutting-edge Multi-disciplinary Technologies”. Forty-five scholars from more than 30 universities and research institutes in China were invited to participate in this forum, and summarized the current status and trend in cancer research, especially the role of cutting-edge technologies in promoting cancer research, the key future research directions, and key scientific challenges. Based on the discussion of forum participants, this review highlights the current status, progress, challenges, and opportunities of cancer research in China, and presents the achievement and importance of multi-disciplinary technologies in driving cancer research and developing cancer therapy and diagnostics. It also summarizes the key scientific questions in the cancer research field for the next 5 to 10 years, and proposes strategies to fund cutting-edge technologies in exploring cancer research in China.

Translational Oncology Toward Benefiting Cancer Patients:The Sun Yat-sen University Cancer Center Experience

Plenary Paper

Translational Medicine in Primary Liver Cancer

A Call for Innovative Translational and Clinical Research to Address China's Unique Cancer Landscape

Importance of translational medicine education in training graduate students of oncology

Tumor Treatment Based on Translational Medicine

Translational Medicine Should Translate Medical Science and Technology into Health Care for Everyone in China

Cancer research driven by cutting-edge multi-disciplinary technologies

Outsmarting Cancer:An International Brainstorm in Guangzhou

Ott_a_225596 9385..9393

1 Concepts , Challenges and Perspectives in Cancer Research

Strengthening translational medicine education in oncology education

Advances in translational medicine for individualized diagnosis of diseases

Unveiling the pan-cancer landscape of S100A16: A comprehensive analysis of prognostic significance, drug sensitivity, and immunomodulatory roles

Precision Cancer Medicine: Deliver a Lasting Blow to Cancer!

Translational research on oral cancer:the current status and con-templation

[Innovations on technology, management and concept are indispensible for scientific research, prevention and treatment of malignant tumor in China].

Status Quo and Prospects of the Translational Research on Lung Cancer in China.

An increase in early cancer detection rates at a single cancer center: Experiences from Sun Yat-sen University Cancer Center

Translational progress on tumor biomarkers.

Current Status and Challenges of Gastrointestinal Cancer Treatment in China